Galleria mellonella infection model demonstrates high lethality of ST69 and ST127 uropathogenic E. coli

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Alghoribi, Majed F ^a,b   Gibreel, Tarek M ^a,f   Dodgson, Andrew R ^c   Beatson, Scott A ^d   Upton, Mathew ^a,e  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

^f UNIVERSITY OF TRIPOLI   (Libyan Arab Jamahiriya)

Author keywords

[No Author keywords available]

Indexed keywords

VIRULENCE FACTOR; O ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; COLONY FORMING UNIT; CONTROLLED STUDY; ESCHERICHIA COLI INFECTION; GALLERIA MELLONELLA; GENE CLUSTER; GENE DELETION; GENE SEQUENCE; GENOME ANALYSIS; LARVAL STAGE; LETHALITY; MOLECULAR PHYLOGENY; MORTALITY; NONHUMAN; NUCLEOTIDE SEQUENCE; SURVIVAL RATE; UROPATHOGENIC ESCHERICHIA COLI; ANIMAL; CLASSIFICATION; COMMUNICABLE DISEASE; GENETICS; HUMAN; LARVA; LEPIDOPTERA; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; SEROTYPE; VIRULENCE;

ANIMALS; COMMUNICABLE DISEASES; HUMANS; LARVA; LEPIDOPTERA; O ANTIGENS; SEROGROUP; UROPATHOGENIC ESCHERICHIA COLI; VIRULENCE;

EID: 84904876324     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101547     Document Type: Article

References (73)

1. Tartof SY, Solberg OD, Manges AR, Riley LW (2005) Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing. J Clin Microbiol 43: 5860-5864. (Pubitemid 43100629)
2. Ronald A (2003) The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon 49: 71-82.
3. Berry RE, Klumpp DJ, Schaeffer AJ (2009) Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli. Infect Immun 77: 2762-2772.
4. Gibreel TM, Dodgson AR, Cheesbrough J, Fox AJ, Bolton FJ, et al. (2012) Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. J Antimicrob Chemother 67: 346-356.
5. Lau SH, Reddy S, Cheesbrough J, Bolton FJ, Willshaw G, et al. (2008) Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing. J Clin Microbiol 46: 1076-1080.
6. Bengtsson S, Naseer U, Sundsfjord A, Kahlmeter G, Sundqvist M (2012) Sequence types and plasmid carriage of uropathogenic Escherichia coli devoid of phenotypically detectable resistance. J Antimicrob Chemother 67: 69-73.
7. Banerjee R, Johnston B, Lohse C, Chattopadhyay S, Tchesnokova V, et al. (2013) The clonal distribution and diversity of extraintestinal Escherichia coli varies according to patient characteristics. Antimicrob Agents Chemother 57: 5912-5917.
8. Johnson JR, Johnston B, Clabots CR, Kuskowski MA, Roberts E, et al. (2008) Virulence genotypes and phylogenetic background of Escherichia coli serogroup O6 isolates from humans, dogs, and cats. J Clin Microbiol 46: 417-422. (Pubitemid 351231280)
9. Nicolas-Chanoine M-H, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, et al. (2008) Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61: 273-281.
10. Croxall G, Hale J, Weston V, Manning G, Cheetham P, et al. (2011) Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings. J Antimicrob Chemother 66: 2501-2508.
11. Johnson JR (1991) Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 4: 80-128.
12. Johnson JR, Stell AL (2000) Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 181: 261-272. (Pubitemid 30049057)
13. Kaper JB, Nataro JP, Mobley HL (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2: 123-140. (Pubitemid 39490066)
14. Lloyd AL, Rasko DA, Mobley HLT (2007) Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli. J Bacteriol 189: 3532-3546. (Pubitemid 46668818)
15. Mylonakis E, Moreno R, El Khoury JB, Idnurm A, Heitman J, et al. (2005) Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect Immun 73: 3842-3850. (Pubitemid 40923121)
16. Mukherjee K, Altincicek B, Hain T, Domann E, Vilcinskas A, et al. (2010) Galleria mellonella as a model system for studying Listeria pathogenesis. Appl Environ Microbiol 76: 310-317.
17. Olsen RJ, Watkins ME, Cantu CC, Beres SB, Musser JM (n.d.) Virulence of serotype M3 Group A Streptococcus strains in wax worms (Galleria mellonella larvae). Virulence 2: 111-119.
18. Leuko S, Raivio TL (2012) Mutations that impact the enteropathogenic Escherichia coli Cpx envelope stress response attenuate virulence in Galleria mellonella. Infect Immun 80: 3077-3085.
19. Wand ME, McCowen JWI, Nugent PG, Sutton JM (2013) Complex interactions of Klebsiella pneumoniae with the host immune system in a Galleria mellonella infection model. J Med Microbiol 62: 1790-1798.
20. Champion OL, Cooper IAM, James SL, Ford D, Karlyshev A, et al. (2009) Galleria mellonella as an alternative infection model for Yersinia pseudotuberculosis. Microbiology 155: 1516-1522.
21. Wand ME, Müller CM, Titball RW, Michell SL (2011) Macrophage and Galleria mellonella infection models reflect the virulence of naturally occurring isolates of B. pseudomallei, B. thailandensis and B. oklahomensis. BMC Microbiol 11: 11.
22. Brennan M, Thomas DY, Whiteway M, Kavanagh K (2002) Correlation between virulence of Candida albicans mutants in mice and Galleria mellonella larvae. FEMS Immunol Med Microbiol 34: 153-157.
23. Cotter G, Doyle S, Kavanagh K (2000) Development of an insect model for the in vivo pathogenicity testing of yeasts. FEMS Immunol Med Microbiol 27: 163-169. (Pubitemid 30047095)
24. Jander G, Rahme LG, Ausubel FM (2000) Positive correlation between virulence of Pseudomonas aeruginosa mutants in mice and insects. J Bacteriol 182: 3843-3845. (Pubitemid 30413039)
25. Clermont O, Bonacorsi S, Bingen E (2000) Rapid and Simple Determination of the Escherichia coli Phylogenetic Group. Appl Environ Microbiol 66: 4555-4558.
26. Li D, Liu B, Chen M, Guo D, Guo X, et al. (2010) A multiplex PCR method to detect 14 Escherichia coli serogroups associated with urinary tract infections. J Microbiol Methods 82: 71-77.
27. Zerbino DR, Birney E (2008) Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res 18: 821-829. (Pubitemid 351645072)
28. Hochhut B,Wilde C, Balling G, Middendorf B, Dobrindt U, et al. (2006) Role of pathogenicity island-associated integrases in the genome plasticity of uropathogenic Escherichia coli strain 536. Mol Microbiol 61: 584-595. (Pubitemid 44324086)
29. Prokka: Prokaryotic Genome Annotation System (n.d.). Available: http://vicbioinformatics.com/. Accessed 20 November 2013.
30. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215: 403-410.
31. Carver TJ, Rutherford KM, Berriman M, Rajandream M-A, Barrell BG, et al. (2005) ACT: the Artemis Comparison Tool. Bioinformatics 21: 3422-3423. (Pubitemid 41222448)
32. Alikhan N-F, Petty NK, Ben Zakour NL, Beatson SA (2011) BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons. BMC Genomics 12: 402.
33. Sullivan MJ, Petty NK, Beatson SA (2011) Easyfig: a genome comparison visualizer. Bioinformatics 27: 1009-1010.
34. Milne I, Stephen G, Bayer M, Cock PJA, Pritchard L, et al. (2013) Using Tablet for visual exploration of second-generation sequencing data. Brief Bioinform 14: 193-202.
35. Samuel G, Reeves P (2003) Biosynthesis of O-antigens: genes and pathways involved in nucleotide sugar precursor synthesis and O-antigen assembly. Carbohydr Res 338: 2503-2519. (Pubitemid 37509950)
36. DebRoy C, Roberts E, Fratamico PM (2011) Detection of O antigens in Escherichia coli. Anim Health Res Rev 12: 169-185.
37. Reyes RE, González CR, Jiménez RC, Herrera MO, Andrade AA, et al. (2012) Mechanisms of O-antigen structural variation of bacterial lipopolysaccharide (LPS). The Complex World of Polysaccharides. Karunaratne DN, ed. InTech.
38. Gibreel TM, Dodgson AR, Cheesbrough J, Bolton FJ, Fox AJ, et al. (2012) High metabolic potential may contribute to the success of ST131 uropathogenic Escherichia coli. J Clin Microbiol 50: 3202-3207.
39. Banerjee R, Robicsek A, Kuskowski MA, Porter S, Johnston BD, et al. (2013) Molecular Epidemiology of Escherichia coli Sequence Type 131 and Its H30 and H30-Rx Subclones among Extended-Spectrum-β-Lactamase-Positive and - Negative E. coli Clinical Isolates from the Chicago Region, 2007 to 2010. Antimicrob Agents Chemother 57: 6385-6388.
40. Desbois AP, Coote PJ (2012) Utility of Greater Wax Moth Larva (Galleria mellonella) for Evaluating the Toxicity and Efficacy of New Antimicrobial Agents. Adv Appl Microbiol 78: 25-53.
41. Evans BA, Rozen DE (2012) A Streptococcus pneumoniae infection model in larvae of the wax moth Galleria mellonella. Eur J Clin Microbiol Infect Dis 31: 2653-2660.
42. Kavanagh K, Reeves EP (2004) Exploiting the potential of insects for in vivo pathogenicity testing of microbial pathogens. FEMS Microbiol Rev 28: 101-112. (Pubitemid 38224509)
43. Peleg AY, Jara S, Monga D, Eliopoulos GM, Moellering RC, et al. (2009) Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics. Antimicrob Agents Chemother 53: 2605-2609.
44. Salzet M (2001) Vertebrate innate immunity resembles a mosaic of invertebrate immune responses. Trends Immunol 22: 285-288.
45. Ratcliffe NA (1985) Invertebrate immunity-a primer for the non-specialist. Immunol Lett 10: 253-270.
46. Walters JB, Ratcliffe NA (1983) Studies on the in vivo cellular reactions of insects: Fate of pathogenic and non-pathogenic bacteria in Galleria mellonella nodules. J Insect Physiol 29: 417-424.
47. Dobrindt U, Blum-Oehler G, Nagy G, Schneider G, Johann A, et al. (2002) Genetic structure and distribution of four pathogenicity islands (PAI I(536) to PAI IV(536)) of uropathogenic Escherichia coli strain 536. Infect Immun 70: 6365-6372. (Pubitemid 35192729)
48. Schneider G, Dobrindt U, Brüggemann H, Nagy G, Janke B, et al. (2004) The pathogenicity island-associated K15 capsule determinant exhibits a novel genetic structure and correlates with virulence in uropathogenic Escherichia coli strain 536. Infect Immun 72: 5993-6001. (Pubitemid 39303714)
49. Blum G, Ott M, Lischewski A, Ritter A, Imrich H, et al. (1994) Excision of large DNA regions termed pathogenicity islands from tRNA-specific loci in the chromosome of an Escherichia coli wild-type pathogen. Infect Immun 62: 606-614. (Pubitemid 24033781)
50. Hacker J, Bender L, Ott M, Wingender J, Lund B, et al. (1990) Deletions of chromosomal regions coding for fimbriae and hemolysins occur in vitro and in vivo in various extraintestinal Escherichia coli isolates. Microb Pathog 8: 213-225. (Pubitemid 20291562)
51. Sarkar S, Ulett GC, Totsika M, Phan M-D, Schembri MA (2014) Role of Capsule and O Antigen in the Virulence of Uropathogenic Escherichia coli. PLoS One 9: e94786.
52. Bender JK, Wille T, Blank K, Lange A, Gerlach RG (2013) LPS structure and PhoQ activity are important for Salmonella Typhimurium virulence in the Gallleria mellonella infection model. PLoS One 8: e73287.
53. Browning DF, Wells TJ, França FLS, Morris FC, Sevastsyanovich YR, et al. (2013) Laboratory adapted Escherichia coli K-12 becomes a pathogen of Caenorhabditis elegans upon restoration of O antigen biosynthesis. Mol Microbiol 87: 939-950.
54. Aballay A, Drenkard E, Hilbun LR, Ausubel FM (2003) Caenorhabditis elegans Innate Immune Response Triggered by Salmonella enterica Requires Intact LPS and Is Mediated by a MAPK Signaling Pathway. Current Biology 13: 47-52. (Pubitemid 36080622)
55. Palusińska-Szysz M, Zdybicka-Barabas A, Pawlikowska-Pawlȩga B, Mak P, Cytryńska M (2012) Anti-Legionella dumoffii Activity of Galleria mellonella Defensin and Apolipophorin III. Int J Mol Sci 13: 17048-17064.
56. Phipps DJ, Chadwick JS, Aston WP (n.d.) Gallysin-1, an antibacterial protein isolated from hemolymph of Galleria mellonella. Dev Comp Immunol 18: 13-23.
57. Tichaczek-Goska D, Witkowska D, Cisowska A, Jankowski S, Hendrich AB (n.d.) The bactericidal activity of normal human serum against Enterobacteriaceae rods with lipopolysaccharides possessing O-antigens composed of mannan. Adv Clin Exp Med 21: 289-299.
58. Noh JY, Patnaik BB, Tindwa H, Seo GW, Kim DH, et al. (2014) Genomic organization, sequence characterization and expression analysis of Tenebrio molitor apolipophorin-III in response to an intracellular pathogen, Listeria monocytogenes. Gene 534: 204-217.
59. Cytryńska M, Mak P, Zdybicka-Barabas A, Suder P, Jakubowicz T (2007) Purification and characterization of eight peptides from Galleria mellonella immune hemolymph. Peptides 28: 533-546. (Pubitemid 46205009)
60. Zdybicka-Barabas A, Sta̧czek S, Mak P, Skrzypiec K, Mendyk E, et al. (2013) Synergistic action of Galleria mellonella apolipophorin III and lysozyme against Gram-negative bacteria. Biochim Biophys Acta 1828: 1449-1456.
61. Brown SE, Howard A, Kasprzak AB, Gordon KH, East PD (2009) A peptidomics study reveals the impressive antimicrobial peptide arsenal of the wax moth Galleria mellonella. Insect Biochem Mol Biol 39: 792-800.
62. Ramamoorthy A, Rosenfeld Y, Shai Y (2006) Lipopolysaccharide (Endotoxin)-host defense antibacterial peptides interactions: Role in bacterial resistance and prevention of sepsis. Biochim Biophys Acta - Biomembr 1758: 1513-1522.
63. Oztug M, Martinon D, Weers PMM (2012) Characterization of the apoLp-III/LPS complex: insight into the mode of binding interaction. Biochemistry 51: 6220-6227.
64. Ortega X, Silipo A, Saldías MS, Bates CC, Molinaro A, et al. (2009) Biosynthesis and structure of the Burkholderia cenocepacia K56-2 lipopolysaccharide core oligosaccharide: truncation of the core oligosaccharide leads to increased binding and sensitivity to polymyxin B. J Biol Chem 284: 21738-21751.
65. Miajlovic H, Cooke NM, Moran GP, Rogers TRF, Smith SG (2014) Response of Extraintestinal Pathogenic Escherichia coli to Human Serum Reveals a Protective Role for Rcs-Regulated Exopolysaccharide Colanic Acid. Infect Immun 82: 298-305.
66. Vincent C, Duclos B, Grangeasse C, Vaganay E, Riberty M, et al. (2000) Relationship between exopolysaccharide production and protein-tyrosine phosphorylation in gram-negative bacteria. J Mol Biol 304: 311-321.
67. Phan M-D, Peters KM, Sarkar S, Lukowski SW, Allsopp LP, et al. (2013) The serum resistome of a globally disseminated multidrug resistant uropathogenic Escherichia coli clone. PLoS Genet 9: e1003834.
68. Bert F, Johnson JR, Ouattara B, Leflon-Guibout V, Johnston B, et al. (2010) Genetic diversity and virulence profiles of Escherichia coli isolates causing spontaneous bacterial peritonitis and bacteremia in patients with cirrhosis. J Clin Microbiol 48: 2709-2714.
69. Johnson JR, Manges AR, O'Bryan TT, Riley LW (2002) A disseminated multidrug-resistant clonal group of uropathogenic Escherichia coli in pyelonephritis. Lancet 359: 2249-2251. (Pubitemid 34717981)
70. Blanco J, Mora A, Mamani R, López C, Blanco M, et al. (2011) National survey of Escherichia coli causing extraintestinal infections reveals the spread of drugresistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-DST69 with high virulence gene content in Spain. J Antimicrob Chemother 66: 2011-2021.
71. Johnson JR, Stell AL, O'Bryan TT, Kuskowski M, Nowicki B, et al. (2002) Global molecular epidemiology of the O15:K52:H1 extraintestinal pathogenic Escherichia coli clonal group: evidence of distribution beyond Europe. J Clin Microbiol 40: 1913-1923. (Pubitemid 34596363)
72. Prats G, Navarro F, Mirelis B, Dalmau D, Margall N, et al. (2000) Escherichia coli serotype O15:K52:H1 as a uropathogenic clone. J Clin Microbiol 38: 201-209. (Pubitemid 30043289)
73. Johnson JR, Menard M, Johnston B, Kuskowski MA, Nichol K, et al. (2009) Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother 53: 2733-2739.